Structure-Activity Relationship of 4,6-Disubstituted Pyrimidines as EGFR and VEGFR-2 Tyrosine Kinase Inhibitors

被引：2
|
作者：
Song, Jiho [1 ]
Lee, Jung Wook [1 ]
Chung, Shin Hyuck [1 ]
Wenas, Michelle A. [1 ]
Min, Kyung Hoon [1 ]
机构：
[1] Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea
来源：
BULLETIN OF THE KOREAN CHEMICAL SOCIETY | 2017年 / 38卷 / 11期
基金：
新加坡国家研究基金会;
关键词：
EGFR; VEGFR-2; Tyrosine kinase inhibitors; Pyrimidine; GROWTH-FACTOR RECEPTOR; BEVACIZUMAB; ERLOTINIB; CANCER; RESISTANCE; THERAPY; CELL;
D O I：
10.1002/bkcs.11278
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
[No abstract available]
引用
收藏
页码：1255 / 1256
页数：2
相关论文
共 50 条
  • [21] Design and SAR of thienopyrimidine and thienopyridine inhibitors of VEGFR-2 kinase activity
    Munchhof, MJ
    Beebe, JS
    Casavant, JM
    Cooper, BA
    Doty, JL
    Higdon, RC
    Hillerman, SM
    Soderstrom, CI
    Knauth, EA
    Marx, MA
    Rossi, AMK
    Sobolov, SB
    Sun, JM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) : 21 - 24
  • [22] Binding mode of VEGF receptor tyrosine kinase KDR (VEGFR-2) inhibitors.
    McGaughey, G
    Bilodeau, M
    Coll, K
    Gibbs, J
    Hartman, G
    Huckle, W
    Hungate, R
    Johnson, A
    Kendall, R
    Koester, T
    Kohl, N
    Mao, XZ
    McFall, R
    Pan, BS
    Rickert, K
    Rodman, L
    Rutledge, R
    Thomas, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U482 - U482
  • [23] Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors
    Qiao, Lixin
    Choi, Sungwoon
    Case, April
    Gainer, Thomas G.
    Seyb, Kathleen
    Glicksman, Marcie A.
    Lo, Donald C.
    Stein, Ross L.
    Cuny, Gregory D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (21) : 6122 - 6126
  • [24] New 2-oxoindole derivatives as multiple PDGFRα/ß and VEGFR-2 tyrosine kinase inhibitors
    Ezelarab, Hend A. A.
    El-Hafeez, Amer Ali Abd
    Ali, Taha F. S.
    Sayed, Ahmed M.
    Hassan, Heba A.
    Beshr, Eman A. M.
    Abbas, Samar H.
    BIOORGANIC CHEMISTRY, 2024, 145
  • [25] Structure-Activity Relationship of Substituted Pyrazoline Derivatives as Small Molecule Tyrosine Kinase Inhibitors
    Akbar, Saleem
    Das, Subham
    Mahto, Aman Kumar
    Dewangan, Rikeshwer Prasad
    Ahmed, Bahar
    CURRENT MEDICINAL CHEMISTRY, 2024,
  • [26] Three-dimensional quantitative structure-activity relationship study of tyrosine kinase inhibitors
    Peng, T
    Pei, HF
    Zhou, JJ
    ACTA PHYSICO-CHIMICA SINICA, 2003, 19 (02) : 163 - 166
  • [27] QSAR and molecular docking studies on oxindole derivatives as VEGFR-2 tyrosine kinase inhibitors
    Kang, Cong-Min
    Liu, Dong-Qing
    Zhao, Xu-Hao
    Dai, Ying-Jie
    Cheng, Jia-Gao
    Lv, Ying-Tao
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2016, 36 (01) : 103 - 109
  • [28] Quantitative structure-activity relationship study of novel, potent, orally active, selective VEGFR-2 and PDGFRα tyrosine kinase inhibitors:: Derivatives of N-Phenly-N′-{4-(4-quinolyloxy)phenyl)urea as antitumor agents
    Sharma, B. K.
    Sharma, S. K.
    Singh, P.
    Sharma, Susheela
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2008, 23 (02) : 168 - 173
  • [29] TRICHOMONACIDAL AGENTS .2. 4,6-DISUBSTITUTED 2-(CYANOAMINO)PYRIMIDINES CARRYING BRANCHED SUBSTITUENTS
    KREUTZBERGER, A
    SELLHEIM, M
    ARCHIV DER PHARMAZIE, 1985, 318 (09) : 801 - 806
  • [30] Design, synthesis and antitumor activity of 4-aminoquinazoline derivatives targeting VEGFR-2 tyrosine kinase
    Yu, Bing
    Tang, Li-da
    Li, Yi-liang
    Song, Shu-hui
    Ji, Xiao-liang
    Lin, Mu-sen
    Wu, Chun-Fu
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 110 - 114
12345